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Suml'l'lary 
We have analyzed  somatic hypermutation of an immunoglobulin (Ig) heavy chain transgene. 
Hybridomas expressing the transgene were produced from immunized transgenic mice and transgene 
copies were sequenced to assay for mutation. In two IgM-producing hybridomas, as well as in 
several IgG-producing hybridomas, mutations were found in the VDJ region of the transgene. 
In the IgM-producing hybridomas, both mutated and unmutated transgene copies were present 
and expressed as mRNA. Several mutated transgene copies were present in a single cell and these 
showed different patterns of mutation. Two IgG-producing hybridomas isolated from a single 
animal also showed a hierarchical pattern of mutation indicating that transgene mutations can 
accumulate during B cell proliferation,  similar to the mutational process for endogenous antibody 
genes. Among hybridomas that expressed both IgG and IgM molecules derived from the transgene, 
the isotype-switched "~ transgene copy exhibited a higher level of mutation than the/~ transgene 
copies. Our results indicate that the 15-kb ARS# transgene contains all the sequence information 
required to target the Ig-specific hypermutational machinery, and raise the possibility that sequences 
associated with the endogenous CH locus might enhance somatic mutation. 
S 
omatic hypermutation contributes to the diversification 
of the antibody H and L chain V(D)J gene segments and 
is important for affinity maturation of antibody responses 
(1-6). Despite the extensive evidence of Ig gene hypermuta- 
tion, little is known about the sequences that target this pro- 
cess to the V(D)J regions of H and L chain genes. Mutations 
are localized within an '~2-kb region surrounding the V(D)J 
exon (7-11) of either productively or nonproductively rear- 
ranged genes (12-14). Mutations are rare in germline, V, J~, 
and J. segments (15, 16). In addition, incomplete DJ-joined 
H chain alleles show levels of mutation much lower than found 
in comparable V(D)J-joined alleles (13, 17). These findings 
suggest that sequences associated with the V gene segment 
and the J gene segment might both be required for efficient 
hypermutation of a recombined Ig gene. 
Rearranged H chain and K L chain transgenes introduced 
into the germline of mice have also been shown to be sub- 
strates for somatic hypermutation (18-21). This indicates that 
transgenic mouse models might be used to localize the c/s- 
acting Ig gene sequences required for targeting the hyper- 
mutational mechanism. We have previously reported that a 
/~ H  chain transgene can undergo isotype switching by an 
interchromosomal  DNA recombination mechanism and that 
the transgene VDJ region was frequently somatically mu- 
rated in the switched transgene copy (21). This suggested 
that the transgene VDJ region might contain the sequence 
elements required to target the hypermutational mechanism. 
However, because the transgene VDJ region was juxtaposed 
to the endogenous CH locus in these switched transgene 
copies, it was not clear whether the sequences required to 
target hypermutation were provided by the transgene, the 
endogenous CFI region, or both. 
To determine whether the ARS/~ transgene contains all 
the sequences required for targeting hy~ermutation, we have 
now analyzed  the VDJ sequences of #  transgene copies in 
hybridomas that have not undergone isotype switching. We 
find that mutated/~ transgene copies  are present in IgM- 
producing hybridomas derived from immunized transgenic 
mice. Within individual hybridomas both mutated and un- 
mutated transgene copies are present, different mutated trans- 
gene copies display different somatic mutations, and both mu- 
tated and unmutated transgene copies are transcribed.  The 
transgene mutations that we detect in IgG- and IgM-producing 
hybridomas are point mutations localized largely to the VDJ 
region, and our results indicate that mutations can accumu- 
late successively  during cell proliferation. These features mimic 
normal Ig gene hypermutation and suggest that the same 
mechanisms are involved in hypermutation of both endoge- 
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munized transgenic mice that express both IgM and IgG de- 
rived from the transgene, the isotype-switched 3' transgene 
copies display significantly higher levels of mutation than the 
/z transgene copies, Based on our results,  we conclude that 
the sequence elements required for targeting the hypermuta- 
tional mechanism appear to be present on the 15-kb ARS# 
transgene DNA segment. We also discuss models to account 
for the different levels of mutation in/x and 3' transgene copies. 
One possibility that we consider is that sequences located 
near the Cy region might enhance somatic hypermutation. 
Materials  and  Methods 
Transgenic Mic~  Transgenic  mice have  been described  previously 
(21). The 15-kb transgene is composed of a recombined VDJ gene 
isolated from the A/J-derived hybridoma  R16.7 and BALB/c-derived 
C/z. The transgene (ARS#) encodes an Ig H chain which, when 
associated with an appropriate L chain, makes CRI^ positive anti- 
Ars antibody. All mice used in this study were derived from the 
ARS5 transgenic line, which contains ,~30-50 copies of the trans- 
gene per cell (21). The transgene copies in ARS5 mice are located 
on mouse chromosome 5 and are arranged predominantly in a 
tandem head to tail array (21, 22). 
Hybridomas and Antibodies.  IgM hybridomas  that were analyzed 
by RNase protection were obtained by fusing transgenic spleen 
cells with the Sp2/0-Agl4 myeloma line. (ARS5  x  BALB/cJ)Ft 
transgenic mice were immunized twice with 100 #g of  ARS-KLH 
in  CFA intraperitoneaUy and,  7  d  before fusion, boosted  in- 
traperitoneally with 100/xg of ARS-KLH in saline. The hybrid- 
omas 1G10, 1E9, and 2B4 have  been described  previously (21). All 
IgG, IgM double-producing hybridomas (except 1G10) were also 
obtained from this fusion. The mAbs RS3.1 (23) and MB86 (24) 
were used to assay  for/z  ~  and #b allotypes, respectively. Microtiter 
wells were coated with RS3.1 (5/~g/ml) or MB86 (10/xg/ml), ex- 
posed to samples, and developed  using biotin-labeled  RS3.1 or MB86 
(200 ng/ml) and mI-labded streptavidin. Test samples were com- 
pared with standards using TEPC 183 (#') and H4.2.5 (#b) mAb, 
as well as BALB/c (#')  and C57BL/6  (#b) sera. Assays for anti- 
AKS reactivity, CKI^ idiotypes, and AD8  reactivity were de- 
scribed previously (21). 
RNase Protection Assay.  The in vitro synthesis of 32p-UTP-la- 
baled RNA probe, hybridization, and RNase digestion were per- 
formed according  to the specifications  of Promega Biotec (Madison, 
WI), The 32P-labeled RNA probe was generated by transcribing 
the antisense  strand of  pGARP with SP6 RNA polymerase,  pGARP 
contains the transgene  VDJ in the pGemini (Promega  Biotec)  vector 
(see Fig. 2 a). Transcripts from this vector initiated from the T7 
KNA polymerase promoter (the sense strand) gave no signal in 
protection assays  with any of the RNAs used in this study. After 
phenol/chloroform extraction and ethanol precipitation, the KNA 
probe was resuspended in hybridization buffer (80% formamide, 
40 mM Pipes, pH 6.7, 0.4 M NaC1, 1 mM EDTA). Hybridoma 
mKNA was added to the probe, hybridized at 42~  overnight, 
and the samples were treated with RNase A (40 #g/ml) and KNase 
T1 (2 #g/ml) for 30 rain at 15~  Digested hybrids were analyzed 
on a 6% denaturing acrylamide gel and exposed to X-ray film at 
- 70  ~ 
cDNA and Genomic DNA Library Construction.  To construct 
a cDNA library from hybridoma 2C7, 100 #g of 2C7 mRNA was 
used to synthesize oligo-dT-primed double-stranded cDNA using 
the Librarian  TM  cDNA library construction system (Invitrogen, 
San Diego, CA). cDNA fragments between 1.5 and 3.5 kb were 
purified from an agarose gel and ligated into bacteriophage Xgtl0. 
Approximately 6  x  l& recombinant phage were screened with 
32p-labeled V133, a probe containing  133 bp  corresponding to 
amino acids 15-59 of VH 36-65 (25). Purified phage clones from 
three separate plugs were analyzed. 
To produce an EMBL3 genomic DNA library, 2C7 genomic 
DNA was digested with BglII. DNA fragments of 12-19 kb were 
purified on an agarose  gel and ligated into BamHI-digested  EMBL3 
arms. For the )~gtl0 2C7 genomic DNA library, 4.4-6.6 kb EcoRI 
fragments were ligated to Xgtl0 arms. Phage libraries were screened 
with 32p-labeled  J.3-4 and V133 probes separately. Plaques that hy- 
bridized to both probes were purified and analyzed. 
PCR, Clonin~ and Sequencing.  The transgene VDJ region was 
PCK amplified  from either hybridoma genomic DNA or cDNA, 
using the primer pairs as shown in Fig. 1. Hybridoma cDNA was 
synthesized using the J,2, #, or 3' primers, as required. PCK pro- 
tocols of either 30 cycles of 1 min denaturation at 94~  3 min 
annealing at 57~  and 2 min extension at 72~  or 30 cycles of 
I min denaturation at 94~  2 min annealing at 55~  and 3 min 
extension at 72~  were used. Genomic transgene clones  in EMBL3 
or ~,gtl0 bacteriophage vectors were PCK amplified  directly from 
the phage plug using primer sets specific for either the transgene 
VDJ region, the enhancer region, or the CH1 region (Fig. 1). PCR 
products were digested with the appropriate restriction enzymes, 
cloned in pUC18, and sequenced  by the dideoxy method (26) using 
pUC sequencing  primers. For the EMBL3 genomic  clone, two PCR 
clones were sequenced and found to be identical. Transgene VDJ 
regions of ~gt.2C7 clones  were PCR amplified,  and the PCR prod- 
ucts were purified  on an agarose gel and sequenced  using the f-tool  TM 
DNA sequencing system (Promega Biotec). For hybridomas ex- 
pressing 3" transgene  copies, two PCK clones  derived  from 3" cDNA 
were sequenced. In each case the two PCK clones were identical. 
Denaturation Gradient Gel Electrophoresis (DGGE)  l.  The trans- 
gene VDJ regions of Xgt.2C7 clones  were PCK amplified  for DGGE 
analysis. PCR conditions were as above. The two nested sets of 
primers are shown in Fig. 1. A 40 base GC-clamp was included 
in the internal 5' primer of the nested PCK primer set to increase 
the sensitivity of the DGGE assay (27, 28). The PCK products 
were fractionated on a 4% polyacrylamide  gel containing a 15% 
to 40% denaturant gradient. 100% denaturant was composed of 
40% (vol/vol) formamide and 7 M urea. Electrophoresis  was per- 
formed at 150 V for 3.5 h in a 60~  water bath. The gel was stained 
with ethidium bromide and the DNA was visualized  with UV light. 
Preparation of  Metaphase Spreads and In Situ Hybridization.  Cells 
from hybridomas 2C7.F5, 4C5.Fll, and 5A2.A11 were harvested 
by standard methods and spread on microscopy slides. The AKS# 
plasmid (21) was nick translated with Bio-dUTP (Sigma Chemical 
Co., St. Louis, MO) for in situ hybridization. Washing, blocking, 
detection, and amplification were described previously (22). 
Results 
Detection of Mutations in  Transgene-encoded IgM by RNase 
Protection.  To screen rapidly for mutations in IgM hybrid- 
omas from transgenic mice, we used an RNase protection 
assay which had the potential to detect mutations in one ex- 
pressed copy of the transgene amidst a possible background 
1 Abbreviation used in this  paper: DGGE, denaturation  gradient  gel electro- 
phoresis. 
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EcoR1 
10. R: 5'-GGAATTCCGGGGCCAGTGGATAGAC-3' 
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Figure  1.  PCR primers. (a) Primer set (1,2) was 
used for PCR amplification of the transgene VDJ 
from DNA templates.  Primer sets (5,6) and (7,8) 
were used to amplify the/~ enhancer and C#1 from 
the genomic phage clones  containing transgene 
VDJ. Primer sets (1,2) and (3,4) were used to pre- 
pare samples for a DGGE by two rounds of se- 
quential amplification of the transgene VDJ from 
recombinant Xgtl0 phages.  (b) Primer sets (1,9) 
and (I ,10) were used for reverse transcription and 
PCR amplification of the transgene VDJ from/~ 
and y  RNA. (c) Nucleotide sequence of primers 
used  for PCR.  (F and R)  forward and  reverse 
primers, respectively. Restriction enzyme sites in- 
cluded in the primers are  underlined.  The  GC 
clamp attached at the 5' end of the primer 3 is 
marked in italics. 
of •30-50  unmutated copies. The rationale for this assay was 
based on the known ability of bovine pancreatic RNase A 
to cut at single basepair mismatches  in RNA:RNA  hybrids 
(29-32).  We tested this assay using RNAs from transgene- 
expressing IgG hybridomas  in which the expressed VDJ se- 
quence had previously been determined.  Hybridomas  1E9, 
1G10, and 2B4 have 1, 7, and 17 mutations, respectively,  in 
the VDJ region of the expressed 3/transgene copy (21, 22). 
Mutations are successfully detected by this assay in 1G10 and 
2B4 (Fig. 2 b). Bands corresponding to protection of the probe 
over the entire  VDJ region (378 bp) are not observed.  In- 
stead,  smaller protection bands are found. The single C  to 
G substitution present in 1E9, however, was not revealed on 
this assay by RNase protection (Fig.  2 b), probably because 
G:G mismatches  are not cleaved by RNase  A  (32).  Thus, 
although the protection assay cannot detect  all point muta- 
Figure  2,  (a) Map of the transgene VDJ probe used for RNase protection experiments.  Neighboring PstI fragments containing transgene VDJ 
sequences were cloned into pGem-3. This coding region is indicated by a white box; (black lines) intron sequences.  (Crosshatched) Plasmid sequences. 
(Arrows) Direction of in vitro transcription from the bacterial promoters SP6 and T7 (black boxes). 32P-labeled antisense  transcripts generated from 
the HindlII-linearized plasmid using T7 polymerase did not protect mRNA from transgene-expressing  cells (data not shown). (b) RNase protection 
analysis of ARS-reactive, transgene-expressing  hybridomas. Hybridomas 1E9, 2B4, and 1G10 are somatically  mutated, IgG-secreting transgenic hybrid- 
omas (21, 22).  All others are IgM-secreting transgenic hybridomas. The 378 base-protected VDJ fragment is indicated. 
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Figure 3.  Comparison oftrans- 
gene VDJ sequences found in IgM 
hybridoma  2C7 to ARS/A. Sequences 
identical to ARS~ (21) are indicated 
either by a solid line or by a dash 
within those codons  that exhibit 
mutations.  Position  numbers  of 
codom cont~ning  mutated bases are 
shown. Amino acids of ARS~ (top) 
and  the  replacement  (bottom)  at 
mutated codons are also indicated. 
(a)  E3.2C7  is  an EMBL3 clone, 
~gt.2C7.1-11 are )~gtl0 clones,  both 
obtained  from  genomic libraries. 
2C7.pl-p4 are genomic PCR clones. 
(b) 2C7.cl-c3 are Xgtl0 clones ob- 
tained from a 2C7 cDNA library, 
and 2C7.rl-r11 are PCR clones de- 
rived from 2C7 cDNA. 
tions equally well, this approach does identify some mutated 
VDJ regions in expressed transgene copies. 
RNAs from 16 IgM transgene-expressing hybridomas that 
were derived from immunized transgenic mice, were screened 
by RNase protection analysis (Fig. 2 b). Partially protected, 
smaller-sized bands were observed in 2C7, indicating the ex- 
pression of mutated transgene copies in this cell line. The 
presence of strong full-length protected bands in 2C7 also 
suggested either expression of unmutated transgene copies, 
or expression of copies that had mutations that were not re- 
vealed by the RNase protection assay. Other hybridomas in 
Fig. 2 b (such as 2G8) displayed low levels of smaller-sized 
protection bands, but these were weak and shared by many 
of the cell lines. Thus, any suggestion of mutated copies in 
these hybridomas by the protection assay was marginal. 
Mutations in the Transgene V Region in an IgM Hybridoma. 
To determine whether the transgene copies in 2C7 displayed 
somatic mutations, we sequenced transgene VDJ regions in 
2C7  genomic DNA  by two approaches.  First,  we PCR- 
amplified the transgene VDJ regions from 2C7 genomic DNA, 
isolated PCR clones, and sequenced individual clones. Among 
four of these 2C7 DNA PCR clones, two did not exhibit 
any mutations and two clones had two and three mutations, 
respectively, in the 470-bp VDJ region sequence (Fig. 3 a). 
We have determined that the error rate of Taq polyrnerase 
in our system is ~1/2,500 by sequencing 10 transgene VDJ 
region PCR clones (470 bp/clone) obtained from 30 cycles 
of PCR amplification of transgenic kidney DNA. This is six- 
fold less than the rate of mutation found in the PCI~ clones 
of the transgene V regions in 2C7. Thus, although the overall 
frequency of mutations in the 2C7 DNA PCR clones is low 
(1/390), our results suggest that some of these reflect gen- 
uine somatic mutations. 
To investigate mutation of transgene copies in 2C7 using 
a second approach, EMBL3 and Xgtl0 genomic libraries of 
2C7 DNA were constructed and the phage clones containing 
transgene VDJ sequences  were isolated. One EMBL3 (E3.2C7) 
clone and eleven Xgtl0 (Xgt.2C7.1-11)  genomic clones that 
contained the  transgene VDJ  region were obtained.  For 
E3.2C7,  sequences of the VDJ region and portions of en- 
hancer and C regions were determined. Three mutations were 
found in the 470-bp VDJ region (Fig. 3 a), whereas no mu- 
tations were found in the 600-bp enhancer and 350-bp C re- 
gion sequences. 11 Xgtl0 clones were screened for mutations 
by DGGE after PCR. amplification in the VDJ region covering 
CDR1 to CDR3.  10 of these showed no band shift upon 
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genomic  clones  was PCK amplified  and the PCK products  were  analyzed 
by denaturing  gradient PAGE to screen  for the presence  of mutations. 
DGGE and showed no mutations in subsequent sequence  anal- 
yses. One clone, Xgt.2C7.3, did show a band shift upon DGGE 
analysis (Fig. 4),  suggesting the presence of mutation. Se- 
quence analysis of 2~gt.2C7.3 demonstrated three mutations 
in the VDJ region (Fig. 3 a), but no mutations in the 600-bp 
enhancer region.  Thus,  analyses of these genomic clones 
confirmed that some # transgene copies were mutated in the 
2C7 hybridoma and indicated that transgene mutations were 
localized to the region surrounding the VDJ exon. 
Expression of Mutated and Unmutated Transgene Copies in 
2CZ  To investigate whether mutated transgene copies in 
2C7 were expressed at the KNA level  we used two approaches 
to sequence  the transgene VDJ regions present in 2C7 mRNA. 
First, three transgene cDNA clones (2C7.cl-c3) were derived 
from a 2C7 )~gtl0 cDNA library and sequences of the VDJ 
and CH1 regions were determined. As shown in Fig. 3 b, 
each of the three clones exhibits two mutations within the 
VDJ region. Two clones, 2C7.cl and 2C7.c2 have identical 
mutations, one at codon 37 and the other at codon 57. The 
third cDNA clone, 2C7.c3,  also has two mutations, both 
within codon 110. For the CH1 region, one mutation was 
found in 2C7.cl, whereas no mutations were found in 2C7.c2 
and 2C7.c3. 
Subsequently, we PCK-amplified transgene cDNA from 
2C7 mKNA, isolated PCR clones, and sequenced the VDJ 
region of 11 cDNA PCR clones (2C7.cl-2C7.r11;  Fig. 3 b). 
Among these, eight clones were unmutated, and three clones 
had two mutations each. Remarkably, each of the three mu- 
tated clones exhibited identical mutations (one at codon 37 
and the other at 57) These mutations were the same as found 
in two of the three )~gtl0 cDNA clones, 2C7.cl and 2C7.c2. 
Thus, this pattern of two mutations appears to be present 
at a high frequency among the transgene RNAs in the 2C7 
hybridoma. 
Our sequence analysis of clones derived from 2C7 DNA 
and KNA provides strong evidence for at least four mutated 
transgene copies in the 2C7 hybridoma. Two mutated copies 
are represented by the E3.2C7 and Xgt.2C7.3 genomic clones, 
one mutated copy appears to be represented by several  cDNA 
or cDNA PCR clones (e.g., 2C7.cl), and an additional mu- 
tated copy may  be represented  by a DNA PCR clone (2C7.p2) 
and a cDNA clone (2C7.c3). Although 2C7.p2 and 2C7.c3 
differ by one nucleotide, these two clones do share two mu- 
tations  and the single difference could reflect a PCK error. 
Chromosomal Location of the 2C7 Transgen~  We have pre- 
viously shown that the AKS# transgene can undergo inter- 
chromosomal DNA recombination resulting in the linkage 
of the transgene to the endogenous CH lOCUS (21, 22). Anal- 
ysis of the IgM produced by the 2C7 hybridoma indicated 
expression of the #~ allotype  that  is  characteristic  of the 
transgene C/z, but no detectable expression of the endoge- 
nous #b allotype (data not shown).  This suggests that the 
2C7 transgene array has not recombined to the endogenous 
Ig H chain locus, but remains at the ARS5 chromosome 5 
integration site determined previously (22). To confirm the 
chromosomal  location of  the transgene array in 2C7, we used 
in situ hybridization  with chromosomal metaphase spreads 
under the conditions that we had previously found to yield 
detectable hybridization only to the multicopy transgene array 
(22). Only one site of hybridization proximal to the centro- 
mere of a single chromosome was found in 2C7 (Fig. 5 a); 
this pattern is analogous to our previous findings in normal 
AKS5 cells (22). Thus both serological  and chromosomal anal- 
yses indicate that the transgene copies in 2C7 have not un- 
dergone chromosomal translocation. This demonstrates that 
sequences associated with the endogenous C~ region are not 
involved in mutation of the 2C7 transgene  copies. 
Transgene Mutations in a Second IgM Hybridoma.  To ex- 
plore whether transgene  mutation in the 2C7 hybridoma 
represents a rare event, we analyzed the mutational status of 
a second IgM-producing hybridoma, 2G8. We chose to char- 
acterize 2G8 based on a marginal  suggestion  of mutations 
in our RNase protection assay (Fig. 2 b). Sequence analysis 
of2G8 PCK clones obtained from either genomic DNA (Fig. 
6 a) or cDNA (Fig. 6 b) demonstrated nucleotide changes 
in the transgene VDJ regions.  As found for 2C7,  the fre- 
quency of mutations in the 2G8 genomic DNA PCR clones 
was slightly elevated (threefold) above our background PCR 
error rate. More convincingly, mutations were also found in 
the 2G8 cDNA PCK clones and independent clones exhibited 
the same mutations.  Two of the cDNA PCK clones, 2G8.a3 
and 2GS.b7, which were derived from separate PCK reac- 
tions, exhibited identical patterns of  four mutations. The prob- 
ability that four random mutations in 390 bp of sequence 
would be exactly repeated among 15 clones is on the order 
of 10-11. In addition,  the cDNA PCR clones, 2G8.a2 and 
2G8.b3, also derived from separate PCR reactions, each dis- 
played the same two mutations which were also shared with 
the 2GS.a3 and 2G8.b7 clones (Fig. 6 b). Furthermore, the 
2G8.b8 clone displayed the same four mutations as 2G8.a3 
and 2G8.b7, but also had one additional  nucleotide change 
(Fig. 6 b).  Although we do not know the origin of these 
patterns of related but nonidentical changes between different 
cDNA PCR clones (see  Discussion), the results clearly indi- 
cate the presence of at least one mutated and expressed trans- 
gene copy in 2G8. 
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Metaphase spreads from (a) 2C7, (b) 4C5.Fll, and (c) 5A2.All were hy- 
bridized with pARS/~ (21). (Arrows) Hybridization signals on chromo- 
somes. 2C7 is an IgM-producing hybridoma, whereas 4C5.Fll and 5A2.A11 
are IgM, IgG double-producing  hybridomas. For 2C7,  87/89 analyzed 
cells exhibited one hybridization  signal at a single site on one chromo- 
some. For 4C5.Fll, 93 cells were analyzed; 76 showed signals on both 
a large and small chromosome, 6 showed a signal on a large chromosome 
only, and 11 showed a signal on a small chromosome only. For 5A2.All, 
127 cells were analyzed. 120 showed signals on both a large and small 
chromosome, 3 showed a signal on a large chromosome only, and 4 showed 
a signal on a small chromosome  only. 
Successive Introduction of Transgene Mutations During B Cell 
Proliferation.  As reported previously, the # transgene in ARS5 
transgenic mice can undergo transchromosomal isotype switch 
recombination with endogenous 3' genes after antigenic stim- 
ulation (21, 22).  We have found that, even after  extensive 
subdoning, some hybridomas derived from immunized ARS5 
transgenic mice express and secrete both IgM and IgG trans- 
gene products, as determined serologically, by Northern blot 
and PCR analyses, and by immunoprecipitation  and fraction- 
ation of/z and 3' chain proteins on reducing SDS polyacryl- 
amide gels (data not shown). Two of these double-producing 
hybridomas were also analyzed by in situ hybridization. In 
both, chromosomal translocations of transgene copies similar 
to those described previously (22) were found (Fig. 5, b and c). 
The VDJ sequences of the switched 3' transgenes in nine 
double-producing hybridomas were determined. Five of these 
showed only 0-1 mutations in the y  transgene copy. How- 
ever, hybridomas 4C5.Fll and 5B6.Gll each displayed seven 
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Figure 6.  Comparison of trans- 
gene VDJ sequences found in the 
IgM hybridoma 2G8 to ARS/~. (a) 
2GS.dl-d10  are  genomic  PCR 
clones. Sequences are compared as 
in  Fig.  3.  (b)  2G8.al-a7  and 
2GS.bl-b8 are independent sets of 
cDNA PCR clones derived from 
2G8 mRNA. 
mutations in the 3/transgene copies, whereas hybridomas 
5,2.All and 1G10.C4 each displayed eight transgene muta- 
tions. All of the detected mutations were established by se- 
quencing two different PCR clones. Of the mutations found 
in the 4C5.Fll and 5B6.G11 hybridomas,  five are identical 
in the two cell lines, whereas in each hybridoma two addi- 
tional mutations are unique (Fig. 7). Further analyses  showed 
that 4C5.Fll and 5B6.Gll shared recombined endogenous 
JH alleles as determined by Southern blotting; that both hy- 
bridomas  expressed  somatically  mutated versions  of the 
C57BL/6  Vgl0 L chain gene; and that one somatic muta- 
tion in the expressed V~10 genes was shared by the two hy- 
bridomas (among three Vgl0 mutations in 5B6.G11 and two 
VK10 mutations in 4C5.Fll; data not shown). Because the 
4C5.F11 and 5B6.Gll hybridomas were derived from a single 
immunized transgenic mouse, our data indicate that the two 
hybridomas  represent  fusions of separate B cells that were 
derived from clonal expansion of a common precursor in vivo. 
These results imply that transgene hypermutation can occur 
in stepwise fashion during in vivo proliferation  of antigen- 
stimulated B cells. Analogous findings have been previously 
reported for endogenous Ig genes (33-36).  Thus, our obser- 
vations emphasize the similarity of somatic hypermutation 
for endogenous and transgenic  Ig genes. 
Higher Levels of Mutation in 7  Transgene Copies Among/z, 
7 Double-producing Transgenic Hybridomas.  Previous reports 
have shown that productive and nonproductive V(D)J recom- 
bined alleles in normal B cells exhibit  similar levels of so- 
matic hypermutation (12-14). The/~ and 7 double-producing 
hybridomas that we characterized afforded an opportunity 
to compare directly the level of mutation in # and "y H chain 
transgenes present within a single cell. To focus on B cells 
that had clearly undergone extensive somatic hypermutation, 
we analyzed the three double-producers, 4C5.Fll, 5A2.All, 
and 1G10.C4, which exhibited the largest numbers of muta- 
tions in the 3/transgene copies. Mutations in the/~ transgene 
copies were studied by sequencing PCR clones of/x cDNA 
derived from each hybridoma. As shown in Table 1, in eight 
PCR clones of the #  transgene VDJ from each cell line, a 
total of eight, five, and three mutations were found in 4C5.Fll, 
5A2.A11, and 1G10.C4, respectively.  Thus, the average  number 
of mutations in/x transgene copies (16 mutations/24 copies 
=  0.7) appears to be 10-fold lower than the number found 
in the 3' transgene copy present within the same cell (23 mu- 
tations/3 copies  =  7.7). This 10-fold difference in the fre- 
quency of mutation is likely to be an underestimate due to 
the background of PCR errors in/~ transgene PCR clones. 
Our results clearly indicate that the # and 'y transgene copies 
in these hybridomas do not show equivalent levels of hyper- 
mutation. 
Discussion 
Our studies indicate that an Ig/~ H chain transgene can 
undergo somatic hypermutation without being linked to the 
endogenous Ig locus and, therefore, that the 15-kb transgene, 
which contains the VDJ and C/~ exons as well as surrounding 
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Cell line  Isotype  Clone no.  No. of mutations  Position  and type of mutation 
4C5.F11  3,2b 
5A2.A11 
Set  Asn 
7  31(AG*C-*AA*C) 
Lys  Ser 
59(AA*G*--'AG*C*) 
Ala  Ser 
#  al  1  97(G*CA--~T*CA) 
Phe  Ser 
/z  a2  1  64(TT*C'-"TC*C) 
Set  Pro 
#  a3  1  21(T*CC"~C*CC) 
#  a4  0 
Thr  Thr 
#  bl  3  71(ACT*-~ACC  *) 
Val  Ala 
#  b2  1  56(GT*T"~GC*T) 
Gln  stop 
#  b3  1  5(C*AG~T*AG) 
#  b4  0 
Gln  Gin 
3'2b  8  3(CAG*~CAA *) 
Lys  Ile 
59(AA*G*--'AT*A*) 
Ala  Ser 
92(G*CA--'T*CA) 
Tyr  Ser 
/z  a5  1  102(TA*T"~TC*T) 
/z  a6  0 
#  a7  0 
#  a8  0 
Val  Ala 
#  b5  2  -  7(GT*A-~GC*A) 
Tyr  Ser 
#  b6  1  102(TA*T~TC*T) 
Ile  Val 
#  b7  1  48(A*TT-'~G*TT) 
/z  b8  0 
1G10.C4  y2a  8 
Phe  Cys 
-  13(TT*T--~TG*T) 
Thr  Ser 
58(AC*T-~AG*T) 
Phe  Tyr 
108(TT*T)--~TA*T) 
lle  Leu  Tyr  Phe 
34(A*TA~C*TA)  57(TA*T-"TT*T) 
Tyr  Asp  Thr  Thr 
80(T*AC-.-~G*AC)  87(ACA*---~ACG') 
Thr  Thr  Ala  Ser 
78(ACA*-'ACT*)  97(G*CA~T*CA) 
Glu  Asp  Phe  Leu 
46(GAA*--~GAT  *)  56(G*TT--~C*TT) 
Lys  Arg  Glu  Glu 
67(AA*G-~AG*G)  89(GAG*--~GAA  *) 
Ala  Ala 
92(GCA'-~GCG  ") 
Leu  Leu  Pro  Thr 
51(CTT*.--~CTC*)  53(C*CT--~A*CT) 
Lys  Ile  Ile  Ala 
59(AA*  G*-'AT*  C')  69(A*CA'-'~G*CA) 
continued 
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Cell line  Isotype  Clone no.  No. of mutations  Position  and type of mutation 
#  a9  2 
#  al0  1 
/x  all  0 
#  a12  0 
#  b9  0 
#  bl0  0 
#  bll  0 
#  b12  0 
Ser  Thr  Ser  Ash 
31(AG*C~AC*C)  105(AG*C--'AA*C) 
His  His 
-  2(CAC*~CAT*) 
*  Indicates nucleotides changed. 
sequences, contains the sequence elements required for tar- 
geting the hypermutational mechanism to the H chain VDJ 
region. This is the first localization of sequences required for 
H chain hypermutation. Analogous studies have localized se- 
quences important for hypermutation of L chain transgenes 
to a region  of similar  size  (18-20). 
Development of rapid and sensitive screening methods for 
point mutations is likely to be important  in analyses  of so- 
matic mutation in transgenic mice. We have used both RNase 
protection and DGGE as screening methods to detect point 
mutations  in  transgene  VDJ regions.  RNase protection  is 
not able to detect all single base substitutions (29, 31, 32), 
however, this assay enabled us to find IgM hybridomas that 
exhibit mutations among 30-50 # transgene copies. We also 
used DGGE to screen transgene clones for mutations.  It has 
been indicated that DGGE can detect over 95% of single base 
substitution mutations (27, 28). Our DGGE analyses of trans- 
gene clones illustrate the sensitivity of this assay because the 
observed mobility shift for the Xgt.2C7.3 clone was actually 
due to a single A  to T  substitution. 
Microinjected transgenes  occasionally exhibit rare muta- 
tions that may result from the chromosomal integration process 
(37). However, it is unlikely that the mutations we have found 
in # transgene copies represent such events. Mutations intro- 
duced into  transgene copies during  microinjection  will be 
present  in all  cells  and would be found repeatedly among 
different hybridomas.  Yet,  among  122 clones of the trans- 
gene VDJ region in ARS5 mice that  have been sequenced, 
we have not found any examples of mutated transgene copies 
that repeat between different hybridomas. Furthermore, our 
RNAase protection experiments  indicate that  the 2C7 hy- 
bridoma expresses a mutated transgene copy that is not ex- 
pressed in other hybridomas,  and our sequence analysis  of 
two transgene copies isolated from 2C7 shows the localiza- 
tion of mutation in the transgene VDJ region. Taken together, 
these results strongly support our conclusion that the trans- 
gene mutations are introduced by a somatic hypermutational 
process. 
Several characteristics of the transgene mutations that we 
have detected indicate that  the normal Ig gene hypermuta- 
tional process is involved in transgene mutation. First, all trans- 
gene mutations  found in this study are base substitutions. 
In normal Ig genes, over 95% of the mutations are also base 
substitutions (9, 14, 38). Second, mutations in the transgene 
appear to be localized largely to the VDJ region, consistent 
with findings for normal  Ig genes (7, 8, 39).  We did find 
one mutation  in the CH1 exon of 2C7.cl.  This mutation 
could represent an error of reverse transcriptase  during cDNA 
synthesis (40) or a bona fide somatic mutation.  Supporting 
the latter possibility, low levels of mutation in C region genes 
have been reported for CX genes in normal mouse hybrid- 
omas (14).  Finally,  two hybridomas isolated from a single 
immunized animal show a pattern of shared tramgene muta- 
tions that indicates sequential mutation during cell prolifera- 
tion. This is the first demonstration that Ig transgene muta- 
tions accumulate  through  several cell divisions.  A  number 
ARS~ 
31  34  54  57  59 
SER  ILE  GLY  TYR  LYS 
;tGC  ~&TA  C-GR ~  TAT ~ 
80  87 
TYR  THR 
T&C  ~  ACA 
ASN  THR  PHE  SER 
4C5.Fll  -A-  --  c .......  T- --  -c-c  -- 
THR  THR  ARG  PHE  SER 
5B6.G11  -c-  --c-  --  ),  .... ~-  --  -oc  -- 
ASP 
G--  ~  --G  k  f  Figure 7.  Comparison of VDJ 
sequences of 7 transgene copies in 
4C5,Fll and 5B6.Gll to ARS/~. Se- 
quences are compared as in Fig. 3. 
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genes (33-36). 
Sequence analyses of transgene  VDJ regions  from both 
DNA and RNA of the IgM hybridomas show that multiple, 
but not all, transgene copies have undergone mutation and 
at least some of the mutated copies are transcribed. It is in- 
teresting that our results suggest that some transgene copies 
might be overrepresented among transgene RNAs in a single 
cell. In 2C7, 5 out of 14 transgene cDNA-derived clones (36%) 
have the same mutations, i.e., a G to A substitution at codon 
37 and a T to C substitution at codon 57. These mutations 
were not found in any of the 16 transgene clones obtained 
from 2C7 genomic DNA, suggesting  that the majority of 
the transgene copies do not have those particular mutations. 
Similarly, in 2G8,  5 out of 15 cDNA PCR clones (33%) 
display an A to C mutation at codon 98 and an A to T muta- 
tion at codon 102, but none of the 10 genomic DNA PCR 
clones have these mutations. The pattern of mutations among 
2G8 cDNA PCR clones is unusual. 2G8.a2 and 2GS.b3 share 
mutations at codons 98 and 102. These two mutations are 
also observed in three other clones (2G8.a3, 2G8.b7,  and 
2G8.bS), each of which share two additional mutations at 
codons 23 and 24. 2G8.b8 has a further A to G substitution 
at codon 38. This pattern of nested mutations among these 
dones could reflect PCR errors of "template jumping" (41) 
and base misincorporation (42). However, we cannot rule 
out that these results might reflect a role for gene conversion 
in transgene  mutation. 
Our results indicate that several  mutated transgene copies, 
as well as unmutated copies, can be found within a single 
cell. Sharp et al. (20) have also found that multiple x trans- 
gene copies can be mutated within a single B cell and that 
mutated and unmutated copies can be found in the same cell. 
On the other hand, Rogerson et al. (43) have noted that, 
in one K  transgenic mouse line, only one of three ~ transgene 
copies within a single B cell shows high levels of somatic 
mutation (although the particular transgene copy that is mu- 
tated can vary between different B cells) and have suggested 
a role for DNA replication in somatic hypermutation. We 
do not know why some/~ transgene copies are not mutated 
in B cells that have dearly undergone the hypermutational 
process. Possibly this reflects a process, such as DNA replica- 
tion, that might regulate the hypermutational mechanism. 
However, because the number of mutations per/x transgene 
copy that we have found is relatively low, it also seems pos- 
sible that the presence of mutated and unmutated/~ trans- 
gene copies in  a single  cell could be merely a statistical 
phenomenon. 
Our studies of transgene mutation in IgM and IgG double- 
producing hybridomas are the first to assess somatic hyper- 
mutation of/x and 3' genes within a single cell. We find that 
in three hybridomas,/x transgene copies exhibit at least 10- 
fold fewer mutations than the isotype-switched 3' transgene 
copy present in the same cell. These results are intriguing 
because previous reports have indicated that productive and 
nonproductive V(D)J joined genes in a single cell exhibit very 
similar levels of somatic mutation (12-14). There are likely 
to be many plausible models which could account for the 
nonequivalent  hypermutation of/x and 3' transgene copies 
that we observe. Because  we find that several  different/x trans- 
gene copies can be mutated in an IgM-producing cell, we 
suspect that the higher levels of mutation observed in 3' trans- 
gene copies might be related to isotype switching. Increased 
mutation of3' transgene copies could indicate that sequences 
located within or near the C3' locus (perhaps even the en- 
hancer sequence located 3' of the Cot gene [44]) might en- 
hance hypermutation of a transgene VDJ region which is 
juxtaposed to the endogenous C3" region by isotype switching. 
Such an effect would presumably also occur with endoge- 
nous H chain VDJ regions and might account for the larger 
numbers of mutations that are often found in IgG- versus 
IgM-producing B cells in nontransgenic mice (39, 45, 46). 
There is also a precedent for the notion that sequences down- 
stream of the antibody V(D)J region might enhance the fre- 
quency of hypermutation (19, 20). 
The higher levels of 3' transgene mutation that we have 
found in double-producing  B cells could potentially also be 
explained by effects that result from antigenic selection. This 
hypothesis requires several  assumptions. First, because produc- 
tive and nonproductive alleles are mutated at equivalent levels 
in normal B cells (12-14), it is clear that normal somatic hyper- 
mutation rates are so high that silent mutations are coselected 
with mutations that affect antigen binding. This would sug- 
gest that antigenic selection should not focus mutations in 
the 3" transgene copy within transgenic B cells that express 
both IgM and IgG. However, if the somatic mutation rate 
per gene is lower than normal in multicopy transgenic B cells, 
then it could be suggested that during cell proliferation mu- 
tations in the 3" transgene copy might be preferentially  selected, 
whereas mutations in/x transgene copies might be diluted. 
Preferential antigenic selection of mutations in the 3" trans- 
gene copy could be based on a more effective signal transduc- 
tion for proliferation through surface IgG versus surface IgM. 
As mentioned, this model relies on the assumption of a de- 
creased mutation rate per gene in multicopy transgenic B cells. 
However, previous work has indicated that the frequency of 
mutations per transgene copy in g transgenic mice appears 
to be unaffected by copy number (18, 20). Nevertheless, be- 
cause previous studies have used transgenic mice carrying be- 
tween 3 and 10 transgene copies, it is possible that a decreased 
mutation rate occurs in cells that have higher copy numbers. 
A recent report showing no somatic hypermutation of a 
TCR transgene expressed in B cells under the control of the 
Ig H chain enhancer indicates that the H chain enhancer se- 
quence is irrelevant or insufficient for targeting transgene 
hypermutation (37). Our finding that hypermutational tar- 
geting can be directed by a 15-kb # transgene indicates that 
deletional mutagenesis of H chain transgene constructs can 
lead to the identification  and characterization  of those cis- 
acting sequences  that are required  by the mutational machinery. 
It will also be interesting  to compare transgenes encoding 
/x and 3' H chains to determine whether sequences that en- 
hance mutation might be localized near the C3' exons. 
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